Gregory Anthony Yanik MD

Professor, Pediatrics & Communicable Diseases, University of Michigan Medical School

Education & Training

Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 1988 - 1991
Corewell Health East Beaumont (Royal Oak)Residency, Internal Medicine, 1984 - 1987
Corewell Health East Beaumont (Royal Oak)Internship, Transitional Year, 1983 - 1984
Wayne State University School of MedicineClass of 1983

CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017

PubMed

Parent-to-Child Information Disclosure in Pediatric Oncology.
Rachel A Kentor, Flora Hoodin, Michelle Byrd, Kristin A Kullgren, Leah LaLonde
Pediatric Blood & Cancer. 2026-03-01
Noninfectious pulmonary complications after hematopoietic cell transplantation: a comprehensive review.
Christopher Bertini, Felipe Soto, Rebecca Brown, Lara Bashoura, Guang-Shing Cheng
Respiratory Medicine. 2025-11-01
2 citations
Pirfenidone for the treatment of bronchiolitis obliterans syndrome related to chronic graft-versus-host disease.
Husham Sharifi, Carson Tyler Moss, Zayan Musa, Alexander Bell, Christian O'Donnell
Blood Advances. 2025-10-14

Journal Articles

Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated Donors
Parameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica
Veno-Occlusive Disease After High-Dose Busulfan–Melphalan in Neuroblastoma
Gregory Yanik, Morris Kletzel, Stephan Grupp, David Jacobsohn, Christopher C Dvorak, Alix E Seif, Mark Ranalli, Haydar Frangoul, Nature

Abstracts/Posters

Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World E...
Gregory Yanik, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Molecular Detection of Minimal Residual Disease Precedes Morphological Relapse and Could be Used to Identify Relapse in Pediatric and Young Adult B-Cell Acute Lymphobl...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

New Cellular Therapy Trials for Brain TumorsMarch 14th, 2025
H. Pylori May Hinder Efficacy of Immune Checkpoint InhibitorsAugust 4th, 2021
U-M Rogel Cancer Center First in Michigan to Offer All FDA Approved Car T-cell TherapiesMay 23rd, 2018

BMT Core- University of Michigan Core Clinical Consortium for the BMT Clinical Trials Network (BMT CTN)UNIVERSITY OF MICHIGAN AT ANN ARBOR2001–2031
Parametric Response Mapping (PRM) for the detection of chronic lung injury in hematopoietic cell transplant recipientsUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2026
MIBG W/ Intensive Chemotheryapy &Autologous Stem Cell Rescue For NeuroblastemaNational Center For Research Resources2007
Etanercept For Treatment Of Sub-Acute Pulm Dysfunction After Allogeneic BMTNational Center For Research Resources2007
(MIBG) With Intensive Chemotheryapy And Autologous Stem Cell Rescue For NeuroblaNational Center For Research Resources2006